Showing results (1481-1490 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|November 7, 2020
Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trialMichael J Hale, Anthony Howell, Mitch Dowsett, et al.Breast (Edinburgh, Scotland)|September 1, 2020
Epidemiology of male breast cancerSanthi Konduri, Maharaj Singh, George Bobustuc, et al.Breast (Edinburgh, Scotland)|November 14, 2020
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA studyAnne-Claire Hardy-Bessard, Fabien Brocard, Florian Clatot, et al.Breast (Edinburgh, Scotland)|February 18, 2020
Machine-learned identification of psychological subgroups with relation to pain interference in patients after breast cancer treatmentsReetta Sipilä, Eija Kalso, Jörn LötschBreast (Edinburgh, Scotland)|February 23, 2020
Evaluation of existing patient educational materials and development of a brochure for women with dense breastsErica T Warner, Mark Kennedy, Ariel Maschke, et al.Breast (Edinburgh, Scotland)|January 21, 2020
Teaching cross-cultural design thinking for healthcareMafalda Falcão Ferreira, Julia N Savoy, Mia K MarkeyBreast (Edinburgh, Scotland)|January 21, 2020
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patientsC C Hack, L Häberle, S Y Brucker, et al.Breast (Edinburgh, Scotland)|December 7, 2018
A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian CancerCarolina Velázquez, Eva M Esteban-Cardeñosa, Enrique Lastra, et al.Breast (Edinburgh, Scotland)|December 14, 2018
Estimation of the benefit and harms of including clinical breast examination in an organized breast screening programHuan Jiang, Stephen D Walter, Patrick Brown, et al.Breast (Edinburgh, Scotland)|August 15, 2017
Management of breast ductal carcinoma in situ in Catalonia, Spain: Results from the Grup Oncologic Calalà-Occità-Catalonia survey with 9-year follow upM J Cambra, B Farrús, F Moreno, et al.Pageof 366